CDC Announces Supplemental Funding Opportunity for Continued Zika Response in 2017

Article

The Centers for Disease Control and Prevention (CDC) is announcing the availability of about $70 million in supplemental funding to states, cities, and territories to support continued efforts to protect Americans from Zika virus.

The funding, distributed through CDC’s Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) Cooperative Agreement, will further support activities to protect the health of Americans, especially pregnant women, including epidemiologic surveillance and investigation, improving mosquito control and monitoring, and strengthening laboratory capacity. Funding also will support participation in the U.S. Zika Pregnancy Registry to monitor pregnant women with Zika and their infants.  

States were notified of the funding opportunity announcement on Oct. 19, 2016. All ELC applicants can request funds. The distribution of funds will be determined based on factors such as Zika disease burden, current laboratory and mosquito surveillance and control capacity, the presence of the Zika virus vector (Aedes aegypti and Aedes albopictus mosquitoes), and local Zika virus transmission. CDC continues to work with states and territories to provide emergency resources for critical needs while the agency completes the necessary reviews and approvals of all applications.

 The deadline for applications is 11:59 p.m. ET on Nov. 20. For more information on CDC’s ELC Cooperative Agreement, visit the ELC webpage: http://www.cdc.gov/ncezid/dpei/epidemiology-laboratory-capacity.html.

Newsletter

Stay prepared and protected with Infection Control Today's newsletter, delivering essential updates, best practices, and expert insights for infection preventionists.

Recent Videos
 Brenna Doran PhD, MA, hospital epidemiology and infection prevention for the University of California, San Francisco, and a coach and consultant of infection prevention; Jessica Swain, MBA, MLT, director of infection prevention and control for Dartmouth Health in Lebanon, New Hampshire; and Shanina Knighton, associate professor at Case Western Reserve University School of Nursing and senior nurse scientist at MetroHealth System in Cleveland, Ohio
 Brenna Doran PhD, MA, hospital epidemiology and infection prevention for the University of California, San Francisco, and a coach and consultant of infection prevention; Jessica Swain, MBA, MLT, director of infection prevention and control for Dartmouth Health in Lebanon, New Hampshire; and Shanina Knighton, associate professor at Case Western Reserve University School of Nursing and senior nurse scientist at MetroHealth System in Cleveland, Ohio
In a recent discussion with Infection Control Today® (ICT®), study authors Brenna Doran PhD, MA, hospital epidemiology and infection prevention for the University of California, San Francisco, and a coach and consultant of infection prevention; Jessica Swain, MBA, MLT, director of infection prevention and control for Dartmouth Health in Lebanon, New Hampshire; and Shanina Knighton, associate professor at Case Western Reserve University School of Nursing and senior nurse scientist at MetroHealth System in Cleveland, Ohio, shared their insights on how the project evolved and what the findings mean for the future.